EWTX
Edgewise Therapeutics, Inc.
Latest Form 4:Sale$286KbyDonovan Joanne M. (CMO) · filed Aug 14, 2026
Edgewise Therapeutics, Inc. (EWTX) has 17 SEC Form 4 filings (59 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Aug 14, 2026.
The most active filer is CMO Donovan Joanne M. with 7 filings. Insiders have net sold $14.0M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Kevin Koch
- Employees:117
- HQ:Boulder, CO, US
- IPO:2021-03-26
Insider Buying
$199K
reported purchases (SEC code P)
Insider Selling
$19.5M
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Market Cap
$4.6B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Donovan Joanne M.First in 3 months | CMO | Sale | 6,522 | $286K | Aug 14 | SEC ↗ |
Donovan Joanne M.First in 3 months | CMO | Sale | 2,919 | $127K | Aug 14 | SEC ↗ |
| Chief Scientific Officer | Sale | 5,901 | $258K | Aug 14 | SEC ↗ | |
MOORE JOHN RFirst filing | General Counsel | Sale | 5,016 | $220K | Aug 14 | SEC ↗ |
Derakhshan BehradFirst filing | Chief Business Officer | Sale | 5,100 | $223K | Aug 14 | SEC ↗ |
KOCH KEVINFirst filing | President and CEO | Sale | 17,971 | $785K | Aug 14 | SEC ↗ |
Russell Alan JFirst in 8 months | Chief Scientific Officer | Sale | 200,000 | $7.9M | Jul 2 | SEC ↗ |
| CMO | Sale | 5,230 | $164K | May 5 | SEC ↗ | |
| CMO | Sale | 50,000 | $1.9M | May 5 | SEC ↗ | |
| CMO | Sale | 28,662 | $926K | Apr 2 | SEC ↗ | |
| CMO | Sale | 21,338 | $685K | Mar 31 | SEC ↗ | |
Donovan Joanne M.First filing | CMO | Sale | 16,358 | $507K | Mar 30 | SEC ↗ |
Edris BadreddinFirst filing | Insider | Sale | 115,471 | $3.4M | Jan 23 | SEC ↗ |
Russell Alan JFirst filing | Chief Scientific Officer | Sale | 100,000 | $2.1M | Nov 13 | SEC ↗ |
Fox Jonathan CFirst filing | Director | Purchase | 10,700 | $199K | Nov 13 | SEC ↗ |
Related companies
Edgewise Therapeutics, Inc. is in the Healthcare sector.